tiprankstipranks
Trending News
More News >
Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
India Market

Bal Pharma Limited (BALPHARMA) Financial Statements

Compare
0 Followers

Bal Pharma Limited Financial Overview

Bal Pharma Limited's market cap is currently ₹1.16B. The company's EPS TTM is ₹0.446; its P/E ratio is 14.25; and it has a dividend yield of 1.62%. Bal Pharma Limited is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 3.03B₹ 3.39B₹ 3.04B₹ 2.81B₹ 2.47B
Gross Profit₹ 730.18M₹ 770.20M₹ 1.25B₹ 1.11B₹ 993.03M
Operating Income₹ 197.89M₹ 214.57M₹ 177.23M₹ 149.18M₹ 140.64M
EBITDA₹ 317.63M₹ 320.23M₹ 245.00M₹ 239.71M₹ 257.82M
Net Income₹ 72.15M₹ 73.92M₹ 25.72M₹ 56.12M₹ 47.42M
Balance Sheet
Cash & Short-Term Investments₹ 105.19M₹ 199.29M₹ 74.63M₹ 60.84M₹ 39.71M
Total Assets₹ 3.36B₹ 3.20B₹ 3.13B₹ 2.61B₹ 2.40B
Total Debt₹ 1.50B₹ 1.42B₹ 1.33B₹ 1.07B₹ 1.12B
Net Debt₹ 1.42B₹ 1.38B₹ 1.30B₹ 1.06B₹ 1.11B
Total Liabilities₹ 2.58B₹ 2.50B₹ 2.49B₹ 2.02B₹ 1.87B
Stockholders' Equity₹ 774.16M₹ 692.94M₹ 637.89M₹ 586.27M₹ 535.81M
Cash Flow
Free Cash Flow₹ -145.55M₹ 118.26M₹ -164.89M₹ 192.39M₹ 183.68M
Operating Cash Flow₹ 42.32M₹ 228.06M₹ -18.43M₹ 277.08M₹ 217.81M
Investing Cash Flow₹ -156.53M₹ -188.91M₹ -221.82M₹ -94.85M₹ -49.80M
Financing Cash Flow₹ 90.12M₹ -12.06M₹ 244.00M₹ -181.34M₹ -166.32M
Currency in INR

Bal Pharma Limited Earnings and Revenue History

Bal Pharma Limited Debt to Assets

Bal Pharma Limited Cash Flow

Bal Pharma Limited Forecast EPS vs Actual EPS